The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 328.50
Ask: 330.50
Change: 0.00 (0.00%)
Spread: 2.00 (0.609%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 327.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Numis cuts Kingfisher but raises Next

Tue, 11th Oct 2022 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

----------

FTSE 100

----------

Citigroup raises Centrica to 'buy' (neutral) - price target 81 (97) pence

----------

Citigroup raises Compass price target to 2,260 (2,170) pence - 'buy'

----------

Deutsche Bank raises Coca-Cola HBC target to 2,750 (2,700) pence - 'buy'

----------

Bernstein cuts Tesco price target to 250 (330) pence - 'outperform'

----------

Credit Suisse raises Anglo American target to 3,440 (3,290) pence - 'outperform'

----------

Credit Suisse cuts Antofagasta price target to 1,020 (1,040) pence - 'neutral'

----------

Credit Suisse raises Fresnillo price target to 650 (630) pence - 'underperform'

----------

Credit Suisse raises Rio Tinto price target to 5,800 (5,600) pence - 'outperform'

----------

Credit Suisse raises Glencore price target to 760 (720) pence - 'outperform'

----------

Credit Suisse cuts Severn Trent price target to 2,680 (2,800) pence - 'neutral'

----------

JPMorgan raises DS Smith price target to 388 (378) pence - 'overweight'

----------

Credit Suisse cuts Rightmove price target to 490 (608) pence - 'neutral'

----------

JPMorgan cuts Barclays price target to 180 (200) pence - 'neutral'

----------

JPMorgan cuts NatWest price target to 300 (350) pence - 'neutral'

----------

JPMorgan cuts Lloyds Banking price target to 56 (64) pence - 'overweight'

----------

Numis cuts Kingfisher to 'sell' (reduce) - price target 150 (215) pence

----------

Numis raises Next to 'buy' (add) - price target 6,800 (7,000) pence

----------

FTSE 250

----------

HSBC cuts Sirius Real Estate price target to 124 (138) pence - 'buy'

----------

JPMorgan cuts Virgin Money UK price target to 165 (200) pence - 'neutral'

----------

Barclays cuts Moneysupermarket.com target to 220 (230) pence - 'equal weight'

----------

Barclays cuts Future price target to 1,975 (2,500) pence - 'overweight'

----------

Berenberg cuts Marshalls price target to 280 (380) pence - 'hold'

----------

JPMorgan cuts Johnson Matthey price target to 2,150 (2,600) pence - 'neutral'

----------

Goldman Sachs cuts TI Fluid price target to 132 (179) pence - 'neutral'

----------

SMALL CAP

----------

Jefferies reinitiates ITM Power with 'buy' - price target 185 pence

----------

Jefferies reinitiates Ceres Power with 'hold' - price target 365 pence

----------

Citigroup cuts Ceres Power price target to 800 (1500) pence - 'buy'

----------

Barclays cuts Just Eat Takeaway target to 1,490 (1,940) pence - 'equal weight'

----------

RBC raises Oxford BioMedica price target to 1,110 (1,020) pence - 'outperform'

----------

Barclays starts Glenveagh Properties with 'overweight' - price target 1.20 EUR

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Nov 2022 11:43

Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale

(Sharecast News) - Analysts at Liberum cut their target price for shares Oxford Biomedica arguing that the company's pan-vector offering had yet to reach sufficient scale in order to deliver sustainable profitability.

Read more
22 Nov 2022 10:15

IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy group - Appoints Frank Mathias as chief executive officer and board director, effective March 2023.

Read more
22 Nov 2022 09:30

Oxford Biomedica taps Frank Mathias as its new CEO

(Sharecast News) - Gene and cell therapy specialist Oxford Biomedica announced the appointment of Dr Frank Mathias as its new chief executive officer and a board director on Tuesday, effective from March.

Read more
14 Nov 2022 14:04

Oxford BioMedica sells Windrush court facility for GBP60 million

(Alliance News) - Oxford BioMedica PLC announced on Monday it had exchanged contracts for the sale and leaseback of its Windrush Court facility to Kadans Science Partner for GBP60 million.

Read more
14 Nov 2022 11:22

SMALL-CAP WINNERS & LOSERS: ME Group upgrades outlook on robust demand

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Monday.

Read more
7 Oct 2022 11:04

SMALL-CAP WINNERS & LOSERS: Superdry swings to profit; Halfords falls

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
7 Oct 2022 10:30

Oxford Biomedica extends Oaktree relationship with new loan facility

(Alliance News) - Oxford Biomedica PLC on Friday said that it has completed the partial repayment and amendment of its Oaktree Capital Management LP loan facility, as it looks to extend its relationship with the US banking company further.

Read more
16 Sep 2022 10:51

SMALL-CAP WINNERS & LOSERS: Capita buoyed by contract win and disposal

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
15 Sep 2022 10:27

Oxford Biomedica swings to loss as Covid vaccine winds down

(Sharecast News) - Oxford Biomedica reported a 21% decrease in its first-half total revenue on Thursday, to £64m.

Read more
15 Sep 2022 10:16

Oxford BioMedica swings to interim loss as costs climb, revenue falls

(Alliance News) - Oxford BioMedica PLC on Thursday reported a swing to interim loss and a decline in interim revenue.

Read more
14 Sep 2022 09:57

IN BRIEF: Oxford BioMedica subsidiary signs deal with new partner

Oxford BioMedica PLC - Oxford, England-based gene and cell therapy company - Says subsidiary Oxford Biomedica Solutions LLC has signed a deal with an unnamed new partner, for an undisclosed sum. Says the deal gives the US-based, private biotechnology firm access to Oxford BioMedica Solutions's process and manufacturing platform.

Read more
8 Sep 2022 16:00

UK earnings, trading statements calendar - next 7 days

Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
Thursday 15 September 
Big Technologies PLCHalf Year Results
Brooks Macdonald Group PLCFull Year Results
Checkit PLCHalf Year Results
DFS Furniture PLCFull Year Results
Foresight Solar Fund LtdHalf Year Results
Gresham House PLCHalf Year Results
Hilton Food Group PLCHalf Year Results
IG Group Holding PLCQ1 Results
IGas Energy PLCHalf Year Results
Keystone Law Group PLCHalf Year Results
Kier Group PLCFull Year Results
MJ Gleeson PLCFull Year Results
Oxford BioMedica PLCHalf Year Results
Portmeirion Group PLCHalf Year Results
Regional REIT LtdHalf Year Results
Renishaw PLCFull Year Results
RTW Venture Fund LtdHalf Year Results
THG PLCHalf Year Results
Trainline PLCTrading Statement
Wickes Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Sep 2022 09:12

Oxford BioMedica shares up as license deal signed with new US partner

(Alliance News) - Oxford BioMedica PLC on Wednesday said it signed a license and supply agreement with an unnamed new partner.

Read more
7 Sep 2022 07:42

Oxford Biomedica inks LSA with new US biotech partner

(Sharecast News) - Gene and cell therapy group Oxford Biomedica has struck a new licence and supply agreement with an unnamed US partner.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.